Chambers Michael Andrew's Form 4 filing
Sarepta Therapeutics, Inc. (SRPT) · filed Aug 14, 2023
- Accession no.
- 0001209191-23-045498
- Filed
- Aug 14, 2023
- Trade date
- Aug 11, 2023
- Filing delay
- 3 days
- Rule 10b5-1 plan
- Not checked
This filing lists 1 non-derivative transaction and 0 derivative transactions. Open-market purchases total $2.56M. It was filed 3 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Chambers Michael AndrewCIK 0001932527 | Director |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Aug 11, 2023 | Common Stock | PPurchaseAcquired | +23,686 | $108.05 | +$2,559,272.3 | 237,017 | Indirect |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.